What did @drjencaudle actually say?
Dr. Jen Caudle used Amy Schumer's public account of her Ozempic experience, specifically the vomiting and debilitating fatigue that left her unable to play with her son, as a jumping-off point to explain GLP-1 side effects. Her core claim is that gastrointestinal symptoms are "probably the most common side effects" of drugs like semaglutide (Ozempic, Wegovy). She was careful to say "not everyone gets them" and pushed viewers toward their doctors rather than toward self-dosing. That framing alone puts her a cut above most GLP-1 content on TikTok.
She also noted that dose reduction or switching medications can sometimes ease those symptoms, and she flagged that FDA eligibility criteria exist for a reason. No specific doses were mentioned. No compounded alternatives were promoted. The video is essentially a side-effect explainer tied to a celebrity news hook.
Does the science back this up?
Yes, on the core claim, the evidence is solid. GI side effects are the most frequently reported adverse events in clinical trials for semaglutide and other GLP-1 receptor agonists. The SUSTAIN and STEP trial programs consistently put nausea at the top of the adverse event list.
The STEP 1 trial (Wilding et al., 2021, New England Journal of Medicine) found that nausea occurred in roughly 44% of participants on 2.4 mg semaglutide, vomiting in about 25%, and diarrhea in around 30%, compared to significantly lower rates in the placebo group. A 2022 meta-analysis by Shi et al. in Diabetes, Obesity and Metabolism, pooling data across multiple GLP-1 trials, confirmed nausea and vomiting as the dominant side effect profile for this drug class. The severity spectrum Dr. Caudle describes, from mild to severe, is also accurate. Some patients in post-market surveillance have reported hospitalizations for severe dehydration secondary to vomiting, though that represents a minority. The suggestion that dose titration can reduce GI burden is also supported in the literature, particularly by the slower titration protocols introduced after early semaglutide rollout.
What did they get wrong (or right)?
Mostly right, with one notable omission. Dr. Caudle did not mention that Amy Schumer later disclosed she has Cushing's syndrome, a condition involving excess cortisol that can independently cause weight changes and fatigue. That context matters when using her case as a GLP-1 side effect illustration, since her symptoms may not have been solely medication-driven.
Beyond that omission, the medical content holds up. She avoided the common TikTok trap of implying these drugs are universally safe or trivially easy to stop. She did not overstate the celebrity case as proof of anything, she used it as an entry point. The phrase "shrimbling" in the clip is from Schumer's own words, and Dr. Caudle did not editorialize that experience into something it was not. One minor quibble: she referenced "lagovi," which appears to be a mispronunciation of Wegovy. That is a brand name issue, not a clinical one, but accuracy in drug naming matters on a platform where viewers may go searching for what they heard.
What should you actually know?
GI side effects from GLP-1 drugs are common enough that you should plan for them before starting, not be surprised by them after. The roughly 44% nausea rate from the STEP 1 trial is not a worst-case number, it is the clinical trial average. For some patients, symptoms are transient and resolve within the first few weeks. For others, like Schumer appears to have experienced, they can be severe enough to stop the medication entirely.
Dose titration protocols exist precisely to reduce this burden. Starting low and going slow is not just preference, it is the labeled approach for a reason. If your provider is skipping titration steps or dismissing GI complaints, that is worth pushing back on. Equally important: severe or persistent vomiting is not something to white-knuckle through. Dehydration can escalate quickly, and that warrants medical attention, not a higher dose. Dr. Caudle's bottom line, talk to your doctor and confirm you meet FDA criteria, is the right call. These are not supplements. They are regulated medications with real adverse event profiles.